Status:
TERMINATED
Treating Adolescents With CBT and OBH
Lead Sponsor:
University of New Hampshire
Conditions:
Anxiety Disorders
Depressive Disorder
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this study is to examine various behavioral, social, and emotional changes that result from engaging in an OBH and CBT treatment program designed for adolescents.
Detailed Description
After being informed about the study and potential risks, all study participants, including minors and parent/guardians, giving written informed consent will complete a screening survey. The screening...
Eligibility Criteria
Inclusion
- Between the ages of 13 and 17 years of age
- 5th grade reading level
- For minors, informed assent
- Parental informed consent and adult consent to participate in the study
- Current diagnosis of Depression and/or Anxiety per parent report, parental interview, and score of 65 on the RCADS. Youth with comorbid diagnoses of these listed diagnoses are eligible
- Current secondary diagnosis of Substance Use Disorder (optional)
- Score greater than a 47 on the YoQ-2.0
- Willingness to participate in all aspects of the treatment programs
- Has the ability to carry a pack that is 1⁄4 their body weight
Exclusion
- Primary Diagnosis of Substance Use Disorder
- Antisocial Personality
- Level 2 or higher Autism Spectrum
- Schizophrenia
- Actively suicidal
- Eating disorders
- BMI greater than 34
- Diabetic
- Physical ailments or disabilities limiting person from hiking, camping, backpacking
- Specific medications including Anxiolytics/Benzodiazepines, Opiates, or multiple Antipsychotics and Mood Stabilizers
- Youth who have a positive pregnancy test
- Participation in another treatment or intervention study within one year of beginning the study
- Individuals currently suffering from detoxification as a result of drug use in the last five days. If drug use occurs during this time period, the participant must wait until they have achieved five days of substance free behavior. This is done to prevent contraindications of treatment (e.g., interaction between drugs and the environment)
- Currently practicing violent behaviors to self or others within the past year per Parent Report
- Currently experiencing hallucinations (hearing voices or seeing things that are not there)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04760938
Start Date
February 1 2021
End Date
December 1 2021
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Hampshire
Durham, New Hampshire, United States, 03824